3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugs
Language English Country United States Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
11495582
DOI
10.1021/jm010155x
PII: jm010155x
Knihovny.cz E-resources
- MeSH
- Amphotericin B pharmacology MeSH
- Antifungal Agents chemical synthesis chemistry pharmacology MeSH
- Furans chemical synthesis chemistry pharmacology MeSH
- 4-Butyrolactone analogs & derivatives chemical synthesis chemistry pharmacology MeSH
- Fungi drug effects MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Stereoisomerism MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- 3-(3,4-dichlorophenyl)-5-pivaloylmethyl-2H,5H-furan-2-one MeSH Browser
- Amphotericin B MeSH
- Antifungal Agents MeSH
- Furans MeSH
- 4-Butyrolactone MeSH
3-(Substituted phenyl)-5-acyloxymethyl-2H,5H-furan-2-ones related to the natural product (-)incrustoporine were synthesized and their in vitro antifungal activity evaluated. The compounds with halogen substituents on the phenyl ring displayed much higher antifungal effect against Aspergillus fumigatus than selected representatives of azole antifungal drugs. In particular, the activity (1.34 microg/mL) of the most promising derivative, 3-(3,4-dichlorophenyl)-5-pivaloyloxymethyl-2H,5H-furan-2-one, was comparable to that of amphotericin B (0.5 microg/mL). Preliminary evaluation of the toxicity of the compound was carried out as well. Considering the size and properties of these molecules in comparison with those of amphotericin B, further development of this novel group of antifungals may lead to substances with better pharmacological profiles than that of the standard anti-Aspergillus drug.
References provided by Crossref.org
In vitro antifungal activity of 3-phenyl-2H-benzoxazine-2,4(3H)-diones